Literature DB >> 25205120

Text mining and network analysis of molecular interaction in non-small cell lung cancer by using natural language processing.

Jun Li1, Lintao Bi, Yanxia Sun, Zhenxia Lu, Yumei Lin, Ou Bai, Hui Shao.   

Abstract

Lung cancer including non-small cell lung cancer (NSCLC) and small cell lung cancer is one of the most aggressive tumors with high incidence and low survival rate. The typical NSCLC patients account for 80-85 % of the total lung cancer patients. To systemically explore the molecular mechanisms of NSCLC, we performed a molecular network analysis between human and mouse to identify key genes (pathways) involved in the occurrence of NSCLC. We automatically extracted the human-to-mouse orthologous interactions using the GeneWays system by natural language processing and further constructed molecular (gene and its products) networks by mapping the human-to-mouse interactions to NSCLC-related mammalian phenotypes, followed by module analysis using ClusterONE of Cytoscape and pathway enrichment analysis using the database for annotation, visualization and integrated discovery (DAVID) successively. A total of 70 genes were proven to be related to the mammalian phenotypes of NSCLC, and seven genes (ATAD5, BECN1, CDKN2A, FNTB, E2F1, KRAS and PTEN) were found to have a bearing on more than one mammalian phenotype (MP) each. Four network clusters centered by four genes thyroglobulin (TG), neurofibromatosis type-1 (NF1 ), neurofibromatosis type 2 (NF2 ) and E2F transcription factor 1 (E2F1) were generated. Genes in the four network modules were enriched in eight KEGG pathways (p value < 0.05), including pathways in cancer, small cell lung cancer, cell cycle and p53 signaling pathway. Genes p53 and E2F1 may play important roles in NSCLC occurrence, and thus can be considered as therapeutic targets for NSCLC.

Entities:  

Year:  2014        PMID: 25205120     DOI: 10.1007/s11033-014-3705-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  53 in total

1.  Molecular characteristics of non-small cell lung cancer.

Authors:  M Nacht; T Dracheva; Y Gao; T Fujii; Y Chen; A Player; V Akmaev; B Cook; M Dufault; M Zhang; W Zhang; M Guo; J Curran; S Han; D Sidransky; K Buetow; S L Madden; J Jen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 2.  Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.

Authors:  Helena Linardou; Issa J Dahabreh; Dimitra Kanaloupiti; Fotios Siannis; Dimitrios Bafaloukos; Paris Kosmidis; Christos A Papadimitriou; Samuel Murray
Journal:  Lancet Oncol       Date:  2008-09-17       Impact factor: 41.316

Review 3.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

4.  Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.

Authors:  Amy L McDoniels-Silvers; Caramella F Nimri; Gary D Stoner; Ronald A Lubet; Ming You
Journal:  Clin Cancer Res       Date:  2002-04       Impact factor: 12.531

5.  A genome-wide association study of Cloninger's temperament scales: implications for the evolutionary genetics of personality.

Authors:  Karin J H Verweij; Brendan P Zietsch; Sarah E Medland; Scott D Gordon; Beben Benyamin; Dale R Nyholt; Brian P McEvoy; Patrick F Sullivan; Andrew C Heath; Pamela A F Madden; Anjali K Henders; Grant W Montgomery; Nicholas G Martin; Naomi R Wray
Journal:  Biol Psychol       Date:  2010-08-04       Impact factor: 3.251

6.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.

Authors:  A Bhattacharjee; W G Richards; J Staunton; C Li; S Monti; P Vasa; C Ladd; J Beheshti; R Bueno; M Gillette; M Loda; G Weber; E J Mark; E S Lander; W Wong; B E Johnson; T R Golub; D J Sugarbaker; M Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

7.  P38 MAP kinase mediates apoptosis after genipin treatment in non-small-cell lung cancer H1299 cells via a mitochondrial apoptotic cascade.

Authors:  Xue Yang; Jie Yao; Yue Luo; Yongguang Han; Zuobai Wang; Linfang Du
Journal:  J Pharmacol Sci       Date:  2013       Impact factor: 3.337

Review 8.  Targeted therapies for non-small cell lung cancer.

Authors:  Wolfram C M Dempke; Tamas Suto; Martin Reck
Journal:  Lung Cancer       Date:  2009-11-14       Impact factor: 5.705

9.  Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.

Authors:  Patrick O'Donnell; Jane Ferguson; Johnny Shyu; Robert Current; Taraneh Rehage; Julie Tsai; Mari Christensen; Ha Bich Tran; Sean Shih-Chang Chien; Felice Shieh; Wen Wei; H Jeffrey Lawrence; Lin Wu; Robert Schilling; Kenneth Bloom; Warren Maltzman; Steven Anderson; Stephen Soviero
Journal:  BMC Cancer       Date:  2013-04-27       Impact factor: 4.430

10.  Self-correcting maps of molecular pathways.

Authors:  Andrey Rzhetsky; Tian Zheng; Chani Weinreb
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

View more
  2 in total

1.  Lung cancer in which the hypothesis of multi-step progression is confirmed by array-CGH results: A case report.

Authors:  Daniela Bettio; Anna Venci; Valentina Achille; Marco Alloisio; Armando Santoro
Journal:  Exp Ther Med       Date:  2015-11-16       Impact factor: 2.447

2.  Low expression of long noncoding RNA CDKN2B-AS1 in patients with idiopathic pulmonary fibrosis predicts lung cancer by regulating the p53-signaling pathway.

Authors:  Yufeng Du; Xiaoyan Hao; Xuejun Liu
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.